BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7685977)

  • 1. Hyperproliferation-associated keratin expression in human middle ear cholesteatoma.
    Bujía J; Schilling V; Holly A; Stammberger M; Kastenbauer E
    Acta Otolaryngol; 1993 May; 113(3):364-8. PubMed ID: 7685977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cytokeratins 13 and 16 in middle ear cholesteatoma.
    Sasaki H; Huang CC
    Otolaryngol Head Neck Surg; 1994 Mar; 110(3):310-7. PubMed ID: 7510866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hyperproliferation-associated keratin 16 expression in cholesteatoma].
    Schilling V; Bujía J; Holly A; Schulz P
    Laryngorhinootologie; 1992 Nov; 71(11):584-7. PubMed ID: 1281411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An immunocytochemical study of cytokeratin expression in human middle ear cholesteatoma.
    Chao WY; Huang CC
    Arch Otorhinolaryngol; 1989; 246(1):37-42. PubMed ID: 2472127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokeratin expression in cholesteatoma matrix, meatal epidermis and middle ear epithelium. A preliminary report.
    van Blitterswijk CA; Grote JJ
    Acta Otolaryngol; 1988; 105(5-6):529-32. PubMed ID: 2456666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical analysis of the cytokeratin expression in middle ear cholesteatoma and related epithelial tissues.
    Broekaert D; Coucke P; Leperque S; Ramaekers F; Van Muijen G; Boedts D; Leigh I; Lane B
    Ann Otol Rhinol Laryngol; 1992 Nov; 101(11):931-8. PubMed ID: 1280020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokeratins in induced epidermoid formations and cholesteatoma lesions.
    Vennix PP; Kuijpers W; Tonnaer EL; Peters TA; Ramaekers FC
    Arch Otolaryngol Head Neck Surg; 1990 May; 116(5):560-5. PubMed ID: 1691647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant expression of epidermal growth factor receptor in aural cholesteatoma.
    Bujía J; Holly A; Schilling V; Negri B; Pitzke P; Schulz P
    Laryngoscope; 1993 Mar; 103(3):326-9. PubMed ID: 7680089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of 4F2-activation antigen in middle ear cholesteatoma].
    Holly A; Bujía J; Sanchez-Madrid F
    Laryngorhinootologie; 1993 Jul; 72(7):324-7. PubMed ID: 8369083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokeratin patterns of tissues related to cholesteatoma pathogenesis.
    Van Blitterswijk CA; Grote JJ; Lutgert RW; Hesseling SC; Out CJ; Van Muijen GN; Fransen JA
    Ann Otol Rhinol Laryngol; 1989 Aug; 98(8 Pt 1):635-40. PubMed ID: 2475048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible role of interleukin 1 alpha and interleukin 1 beta in the pathogenesis of cholesteatoma of the middle ear.
    Schilling V; Negri B; Bujía J; Schulz P; Kastenbauer E
    Am J Otol; 1992 Jul; 13(4):350-5. PubMed ID: 1384343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of involucrin in human middle ear cholesteatoma.
    Chao WY; Huang CC
    Am J Otol; 1989 Sep; 10(5):385-8. PubMed ID: 2683803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative cytokeratin distribution patterns in cholesteatoma epithelium.
    Olszewska E; Sudhoff H
    Histol Histopathol; 2007 Jan; 22(1):37-42. PubMed ID: 17128409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen expression of epithelial markers, collagen IV and Ki67 in middle ear cholesteatoma. An immunohistochemical Study.
    Ergün S; Zheng X; Carlsöö B
    Acta Otolaryngol; 1994 May; 114(3):295-302. PubMed ID: 7521107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible autocrine growth stimulation of cholesteatoma epithelium by transforming growth factor alpha.
    Schulz P; Bujía J; Holly A; Shilling V; Kastenbauer E
    Am J Otolaryngol; 1993; 14(2):82-7. PubMed ID: 8484481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restricted expression of Ki-67 in cholesteatoma epithelium.
    Mayot D; Béné MC; Perrin C; Faure GC
    Arch Otolaryngol Head Neck Surg; 1993 Jun; 119(6):656-8. PubMed ID: 7684591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Keratinization of middle ear cholesteatomas. II. A histochemical study of epidermal transglutaminase substrates.
    Broekaert D; Coucke P; Reyniers P; Marquet J
    Eur Arch Otorhinolaryngol; 1990; 247(5):318-22. PubMed ID: 1697471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative immunohistochemical study of cytokeratin and vimentin expression in middle ear mucosa and cholesteatoma, and in epidermis.
    Broekaert D; Cornille A; Eto H; Leigh I; Ramaekers F; Van Muijen G; Coucke P; De Bersaques J; Kluyskens P; Gillis E
    Virchows Arch A Pathol Anat Histopathol; 1988; 413(1):39-51. PubMed ID: 2453971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Autocrine growth mechanisms of cholesteatoma epithelium].
    Schilling V; Holly A; Bujía J; Schulz P
    Laryngorhinootologie; 1993 Jul; 72(7):319-23. PubMed ID: 8369082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokeratin expression patterns in the human tympanic membrane and external ear canal.
    Lepercque S; Broekaert D; Van Cauwenberge P
    Eur Arch Otorhinolaryngol; 1993; 250(2):78-81. PubMed ID: 7685180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.